Market revenue in 2023 | USD 320.6 million |
Market revenue in 2030 | USD 389.0 million |
Growth rate | 2.8% (CAGR from 2023 to 2030) |
Largest segment | Controls |
Fastest growing segment | Calibrators |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Controls, Calibrators |
Key market players worldwide | Siemens Healthineers AG ADR, Abbott Laboratories, Bio-Rad Laboratories Inc, Danaher Corp, Roche Holding AG ADR, Sysmex Corp, QuidelOrtho Corp, Thermo Fisher Scientific Inc, BD, Merck KGaA, Qiagen NV, Hologic Inc, Bio-Techne Corp, Randox, Helena Laboratories, Seracare Life Sciences, Fortress Diagnostics, Microbiologics, TRINA BIOREACTIVES, Cone Bioproducts, Biorex Food Diagnostics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro diagnostics quality control market will help companies and investors design strategic landscapes.
Controls was the largest segment with a revenue share of 48.35% in 2023. Horizon Databook has segmented the Europe in vitro diagnostics quality control market based on controls, calibrators covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of Europe IVD quality control market can primarily be attributed to the increasing demand for quality control products in European countries with flourishing clinical diagnostic industries, such as Germany, the UK, and Italy.
Moreover, continuous research initiatives being undertaken by European manufacturers for the development of new and innovative diagnostic solutions are anticipated to create lucrative opportunities for players offering IVD quality control products.
Several initiatives undertaken by government & private organizations to fund R&D pertaining to the development of effective diagnostics and create awareness are expected to boost the market. Moreover, initiatives to improve pricing policies and innovation.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe in vitro diagnostics quality control market , including forecasts for subscribers. This continent databook contains high-level insights into Europe in vitro diagnostics quality control market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account